Renaissance Capital logo

ARTV News

US IPO Weekly Recap: Insurance and healthcare lead a 4 IPO week

ARDT

A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar: Chile-based LATAM Airlines Group (LTM) filed to cross-list in the US, and its offering is expected to raise $533...read more

Autoimmune biotech Artiva Biotherapeutics offers more shares, prices IPO below the range at $12

Artiva Biotherapeutics logo

Artiva Biotherapeutics, a Phase 1 biotech developing off-the-shelf Natural Killer therapies for autoimmunity, raised $167 million by offering 13.9 million shares at $12, below the range of $14 to $16. The company offered 5.2 million more shares than anticipated....read more

Autoimmune biotech Artiva Biotherapeutics sets terms for $131 million IPO

Artiva Biotherapeutics logo

Artiva Biotherapeutics, a Phase 1 biotech developing off-the-shelf natural killer cell-based therapies for autoimmune diseases, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $131 million by offering 8.7 million shares at...read more

US IPO Week Ahead: July’s first major IPOs feature healthcare and insurance

ARDT

Updated Monday, 7/15. After a quiet post-holiday week, the July IPO market is set to bag its first major deals in the week ahead. Hospital operator Ardent Health (ARDT) plans to raise $300 million at a $3.0 billion market cap....read more